Management of superficial basal cell carcinoma: focus on imiquimod
Beverly RaaschSkin Cancer Research Group, North Queensland Centre for Cancer Research, James Cook University, Queensland, AustraliaAbstract: Superficial basal cell carcinoma comprise up to 25% of all histological sub-types. They are more likely to occur on younger persons and females and although ge...
Saved in:
Main Author: | Beverly Raasch (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Superficial basal cell carcinoma treated with curettage followed by topical imiquimod cream: A retrospective study
by: Andrew L. Ondo, MD, et al.
Published: (2024) -
Reflectance confocal microscopy follow-up of multifocal superficial basal cell carcinomas treated with imiquimod 5% cream
by: Yun-Min Zou, et al.
Published: (2022) -
Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases Tratamento tópico do carcinoma basocelular superficial e nodular pelo imiquimod creme a 5%: observação de 10 casos
by: Cyro Festa Neto
Published: (2002) -
Dermatoscopy-guided therapy of pigmented basal cell carcinoma with imiquimod
by: Husein Husein-ElAhmed, et al.
Published: (2016) -
Imiquimod 5% cream in topical treatment of facial basal cell carcinoma
by: Grubor Svetlana D., et al.
Published: (2015)